The rule of thumb in the pharmaceuticals industry is that it takes a decade to go “from molecule to market”. In fact, it often takes as long as 16 years and plenty of money is spent over that time, including on the 10,000 or so compounds that fail for each drug that becomes a success. In a rare acquisition of a Chinese company involved in research and development, Charles River Laboratories is buying Wuxi Pharma Tech for $1.6bn in cash and stock to capture a bigger slice of that expenditure.
制藥業(yè)的經(jīng)驗之談是：從“分子到市場”要花費10年的時間。事實上，這段過程往往要花費16年，而且其間要投入大量金錢，包括在每種藥物獲得成功之前失敗的那1萬多種化合物上的投入。在一筆頗為罕見的針對中國藥品研發(fā)企業(yè)的交易中，Charles River Laboratories以16億美元的現(xiàn)金加股票形式收購了無錫藥明康德(WuXi AppTec)，希望能夠借此節(jié)省一大筆這類支出。
您已閱讀25%（684字），剩余75%（2045字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務。